Dan is a co-founder and managing partner of DuneGlass Capital, a healthcare services-focused independent sponsor that was founded to help independent healthcare practices realize their full potential.

Dan leverages his experience investing in and managing nine different PPM platforms and completing 50+ tuck-in acquisitions to lead DGC’s investment strategy. He has a particular focus on building management teams to execute the firm’s investments. In addition to chairing Aviva Aesthetics’ board of directors, Dan is CEO and co-founder of Aviva Aesthetics’ sister company in oral and maxillofacial surgery, Allied OMS.

Prior to founding DuneGlass Capital, Dan co-managed healthcare investing for Sterling Partners’ series of institutional funds, where he personally oversaw $250 million of equity transactions and ultimately $1 billion+ of returned capital. Before that, Dan co-founded three companies, raised $3 million of venture capital, and patented a technology product.

Dan earned his MBA from the Kellogg Graduate School of Management at Northwestern and his BA in Biochemistry from Rice University.